PRESS RELEASE published on 02/24/2025 at 18:55, 1 year 5 months ago Inside Information / News release on accounts, results
PRESS RELEASE published on 10/23/2024 at 18:30, 1 year 9 months ago Quarterly financial reporting / Third quarter financial report Clariane reports 6.3% organic revenue growth for the first nine months of 2024, confirming 2024 guidance of over 5% growth. Progress on €1bn disposal plan Revenue Growth Organic Growth 2024 Guidance Clariane Disposal Plan
PRESS RELEASE published on 10/23/2024 at 18:30, 1 year 9 months ago Information financière trimestrielle / Information financière du troisième trimestre
PRESS RELEASE published on 10/08/2024 at 23:24, 1 year 10 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
PRESS RELEASE published on 10/08/2024 at 23:24, 1 year 10 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 09/25/2024 at 09:38, 1 year 10 months ago Franchissement de seuils chez CLARIANE Obligations Convertibles Morgan Stanley Franchissement De Seuils Acquisition D'actions Clariane
BRIEF published on 09/25/2024 at 09:38, 1 year 10 months ago Crossing thresholds at CLARIANE Convertible Bonds Morgan Stanley Acquisition Of Shares Crossing Thresholds Clariane
PRESS RELEASE published on 09/25/2024 at 09:33, 1 year 10 months ago Franchissement de seuils Déclaration de franchissement de seuils par la société Morgan Stanley pour CLARIANE SE sur Euronext Paris Euronext Paris Déclaration Morgan Stanley Franchissement De Seuils CLARIANE SE
BRIEF published on 09/24/2024 at 09:05, 1 year 10 months ago Crossing of thresholds by Morgan Stanley at CLARIANE Voting Rights Capital Morgan Stanley Crossing Thresholds Clariane
BRIEF published on 09/24/2024 at 09:05, 1 year 10 months ago Franchissement de seuils par Morgan Stanley chez CLARIANE Capital Droits De Vote Morgan Stanley Franchissement De Seuils Clariane
Published on 08/10/2026 at 08:00, 2 hours 33 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 33 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 11 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 10:12, 20 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 22 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 43 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 32 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 33 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:22, 1 hour 10 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 10 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 33 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 33 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
